Experimental compound burns fat without sacrificing muscle
ScienceDaily · Nov 20, 2026
Researchers at UC Berkeley discovered a novel compound that boosts energy expenditure, leading to weight loss in mice without significant muscle loss. The treatment also improved blood sugar control and reduced liver fat, and showed additive benefits when combined with existing GLP‑1 drugs like Ozempic. These findings suggest a potential new avenue for obesity therapy that targets metabolism rather than appetite suppression.
Why it matters
Obesity remains a major public‑health challenge, and current drugs mainly curb appetite, often causing muscle loss. A metabolism‑focused therapy could offer safer, more effective weight management and complement existing treatments, impacting millions of patients and healthcare costs.
Key takeaways
- The compound increased mice energy expenditure by up to 18%
- It promoted weight loss while preserving muscle mass
- Blood sugar control and liver fat were both improved
- Combining it with GLP‑1 drugs yielded greater effects than either alone
- Research is still pre‑clinical and limited to animal models